Exelixis (EXEL) Tops Q4 EPS by 10c, offers guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $55.42 +1.43%
Revenue Growth %: +8.8%
Financial Fact:
Interest expense: -12.63M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +8.8%
Financial Fact:
Interest expense: -12.63M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.33, $0.10 better than the analyst estimate of $0.23. Revenue for the quarter came in at $480 million versus the consensus estimate of $481.81 million.
GUIDANCE:
Exelixis sees FY2024 revenue of $1.825-1.925 billion, versus the consensus of $1.829 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Morgan Stanley upgrades Robinhood, sees 43% upside
- Karman Space & Defense acquires Walker Precision Engineering
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
